Bacteria News and Research

RSS

Fecal transplant procedures performed at Sinai Hospital

Sudhir Dutta, M.D., head of the Division of Gastroenterology at Sinai Hospital, performed fecal transplant procedures for two patients with severe clostridium difficile (C. difficile) colitis that did not respond to routine antibiotic and other treatments. C. difficile causes symptoms ranging from mild diarrhea to more serious, sometimes life threatening colon inflammation.

5 May 2011

Anacor first quarter revenues increase to $2.2 million

Anacor Pharmaceuticals reviewed today its first quarter accomplishments and reported financial results for the quarter ended March 31, 2011.

5 May 2011

Devrom is effective for eliminating flatulence, stool odor issues

Flatulence. Everyone has it. Common factors contributing to flatus production are swallowed air and digestion of certain foods in the intestine. Perhaps one of the most embarrassing aspects of flatulence is the smelly odor, but there is a remedy and it is called Devrom.

5 May 2011

UCF to develop safe, inexpensive and effective polio vaccine

An innovative way of making vaccines at the University of Central Florida has attracted the support of the Bill & Melinda Gates Foundation for its potential to make vaccines lessexpensive, more effective and needle free.

5 May 2011

SBS explores ‘superbugs’ on Insight Tuesday 10th May

Since the discovery of penicillin in the early twentieth century, antibiotics have fought infections and diseases that were once life threatening. But over time, many bacteria have become resistant to these drugs and patients are increasingly at risk.

3 May 2011

Germ Genie is also effective against C.difficile infection

Scientists at the University of Hertfordshire, who proved the effectiveness of Germ Genie, a tool to prevent infections from keyboards, have now found that it can kill C.difficile.

3 May 2011

Affinium announces AFN-1252 Phase I study results in staphylococcal infections

Affinium Pharmaceuticals announced today the results of a new multiple ascending dose Phase I study of its novel, selective-spectrum, anti-staphylococcal agent, AFN-1252 in a novel oral formulation.

3 May 2011

Washing hands with contaminated soap can increase bacterial infection

People who wash their hands with contaminated soap from bulk-soap-refillable dispensers can increase the number of disease-causing microbes on their hands and may play a role in transmission of bacteria in public settings according to research published in the May issue of the journal Applied and Environmental Microbiology.

3 May 2011

Oragenics announces availability of oral care probiotics for children and adults

Florida-based biopharmaceutical company Oragenics, Inc. has announced that its oral care probiotics for children and adults will be available in Australia and New Zealand through an exclusive agreement with Australian Pharmaceutical Industries, owner of the Priceline pharmacy retail chain, and one of the leading service providers to the pharmacy industry.

3 May 2011

New research shows honey fights drug-resistant germs

Herbal ingredients and natural nutrients are often capable of supporting different functions within the body, and current research is showing that a certain kind of honey may be useful in fighting drug-resistant germs.

2 May 2011

Bill & Melinda Gates Foundation announces 88 new winners under Grand Challenges Exploration program

The Bill & Melinda Gates Foundation today announced 88 new winners of US$100,000 each to support innovative research that has the potential to dramatically improve lives in some of the world's poorest countries. The funding, made possible through the Grand Challenges Exploration (GCE) program, will enable researchers worldwide to test unorthodox ideas that address persistent health and development challenges.

30 Apr 2011

PURE named winner of CSN 2011 National Child Safety Award

PURE Bioscience, Inc., creator of the patented silver dihydrogen citrate antimicrobial, today announced that Child Safety Network has named PURE the winner of its 2011 National Child Safety Award and has granted PURE Hard Surface disinfectant its Safe Family Seal of Approval.

30 Apr 2011

Bioniche Life Sciences opens new livestock vaccine manufacturing facility

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today officially opened its new Animal Health and Food Safety Vaccine Manufacturing Centre at its corporate headquarters in Belleville, Ontario, Canada.

30 Apr 2011

C3 Jian, West China School of Stomatology to create joint CRC to test oral healthcare products

C3 Jian, Inc.'s Board of Directors today announced that the Company has signed an agreement with the West China School of Stomatology at Sichuan University to create a joint Clinical Research Centre to test new oral healthcare products in human clinical trials.

30 Apr 2011

Food poisoning costs the United States billions: Report

According to a new report published Thursday, 14 different pathogens causing food poisoning cost the United States $14 billion annually in terms of human disease. The report comes from the University of Florida Emerging Pathogens Institute that found that out of all the pathogen-food combinations they studied, campylobacter in poultry was the single worst offender, causing more than 600,000 illnesses per year, hospitalizing more than 7,000 people and costing, annually, $1.3 billion and 9,500 quality-of-life years.

29 Apr 2011

New genetic study suspects Armadillos as source of leprosy in the U.S.

A new genetic study on leprosy bacteria reports that armadillos may be a source of infection in the Southern United States.

29 Apr 2011

New innovative pilot project to combat surgical infections

Roughly one out of every 24 patients undergoing surgery acquires a surgical site infection. With 40 million operations performed in the U.S. each year, between 800,000 and 2 million individuals contract these infections annually.

29 Apr 2011

UIC receives federal contract to develop antibiotics against three bacterial infections

Researchers at the University of Illinois at Chicago's Center for Pharmaceutical Biotechnology have been awarded a federal contract for up to $13.8 million to develop antibiotics to treat anthrax, tularemia and plague.

28 Apr 2011

Researchers identify three enterotypes in human intestinal bacteria

It would appear that in terms of composition, the intestinal bacteria of every individual can be divided into three main groups known as enterotypes. The intestinal bacteria in each enterotype organise themselves into distinct, stable clusters displaying common features.

28 Apr 2011

Scientists identify new risk gene variant for depression

Max Planck scientists uncover surprising genetic links. Scientists from the Max Planck Institute for Psychiatry in Munich have compared the genomes of a total of 4,088 patients and 11,001 healthy control subjects from all over the world and identified a new risk gene variant for depression.

28 Apr 2011